I've traded in an out of ERIC for several years. The lows keep getting lower and cash keeps making up a greater percentage of its share price. Cash after debt now is 1/3 of ERIC's share price....the 6% div also is favorable for mitigating downside risk.
Japan up 7% in 2 days on stimulus hopes. If all was okay stimulus wouldn't be needed. China slow down continues to deepen. Earnings on deck - the Fed already telegraphed they won't be good due to slow economy.
Take the opportunity to Sell!
great company and great value........10% of my portfolio went into sedg at $18.5/share
I looked at Gilead's board of directors today and do not like what I saw. They seem like a bunch of rich white people who are big wheels in California, but insignificant globally. Where is the ethnic and cultural diversity. Gilead's board needs to be overthrown.
150 million people globally with HCV....it's not a problem limited to California. The board should reflect the global markets that GILD isn't pernetrating....The board is too entrenched.
Davita Healthcare,,,,,Garry E. Menzel to become its chief financial officer. Menzel, 48, previously was CFO at Regulus Therapeutics RGLS......the RGLS connection to dialysis and kidney failure?